Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Hodgkin Disease 7Carcinoma, Non-Small-Cell Lung 7Lymphoma 6Lung Neoplasms 6Recurrence 3Testicular Neoplasms 1Teratoma 1Pathologic Complete Response 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Mesothelioma, Malignant 1Lymphoma, Large-Cell, Anaplastic 1Kidney Neoplasms 1Glioma 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

aldesleukin 9Sunitinib 5Interferon-alpha 4Chemotherapy, Adjuvant 4pembrolizumab 3Vincristine 3Neoadjuvant Therapy 3Dactinomycin 3Cyclophosphamide 3Bevacizumab 3sargramostim 2fludarabine phosphate 2Robotic Surgical Procedures 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Laparoscopy 2Gene Expression Profiling 2Fluorouracil 2Etoposide 2Electroporation 2Doxorubicin 2Carboplatin 2Blood Specimen Collection 2Amplified Fragment Length Polymorphism Analysis 2tremelimumab 1toripalimab 1temsirolimus 1spartalizumab 1pazopanib 1orantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Kidney Neoplasms × Vinblastine × Clear all
NCT00003181 2013-12-04

Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
35 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡